Santosh S. Waigankar (@sandoc2005) 's Twitter Profile
Santosh S. Waigankar

@sandoc2005

UroOnco & Robotic Surgeon Tech_crazy, love making friends, go-getter Persistent Learner, Researcher, Surgical-Scientist. Prostate Focal Therapy Fellow @ UCLH

ID: 99660538

calendar_today27-12-2009 07:05:51

1,1K Tweet

630 Followers

1,1K Following

PRIME Trial UCL (@compassurology) 's Twitter Profile Photo

⛳️ To finish off 🙌🏼 the #PRIME milestones, we are proud to announce the fantastic recruitment of our UK sites 🇬🇧 throughout the past year and a bit! 🚀✨ 🌟 CamUrology: 3️⃣5️⃣➕ 🌟 UCLH: 2️⃣5️⃣➕ 🌟 Royal Free London: 5️⃣➕ #UroSoMe #prostatecancer #prostateMRI

⛳️ To finish off 🙌🏼 the #PRIME milestones, we are proud to announce the fantastic recruitment of our UK sites 🇬🇧 throughout the past year and a bit! 🚀✨

🌟 <a href="/CamUrology/">CamUrology</a>: 3️⃣5️⃣➕
🌟 <a href="/uclh/">UCLH</a>: 2️⃣5️⃣➕
🌟 <a href="/RoyalFreeNHS/">Royal Free London</a>: 5️⃣➕

 #UroSoMe #prostatecancer #prostateMRI
Sachin Tendulkar (@sachin_rt) 's Twitter Profile Photo

Despite losing the first Test, #TeamIndia bounced back impressively to clinch the series with a comfortable 4-1 scoreline. Throughout the series, the team has capitalised on every opportunity presented to them. Kuldeep yadav and Ashwin 🇮🇳's outstanding performances were

Despite losing the first Test, #TeamIndia bounced back impressively to clinch the series with a comfortable 4-1 scoreline.

Throughout the series, the team has capitalised on every opportunity presented to them. <a href="/imkuldeep18/">Kuldeep yadav</a> and <a href="/ashwinravi99/">Ashwin 🇮🇳</a>'s outstanding performances were
Veeru Kasi (@veerukasi) 's Twitter Profile Photo

🚨 Breaking results 🚨 @PrimeMRI study presented at #EAU24 European Association of Urology (EAU). This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI & should be the new standard for prostate cancer diagnosis if image quality is good

🚨 Breaking results 🚨 @PrimeMRI study presented at #EAU24 <a href="/Uroweb/">European Association of Urology (EAU)</a>. This 🌍 multicentre trial (n=555, 22 sites) showed that biparametric MRI without contrast is non-inferior 2 multiparametric MRI &amp; should be the new standard for prostate cancer diagnosis if image quality is good
Santosh S. Waigankar (@sandoc2005) 's Twitter Profile Photo

Prostate calcifications are deterrents for post gland treatment modalities like #HIFU paving the way for more effective anterior gland treatment modalities of #cryotherapy and #Nanoknife ⁦⁦Focal Therapy Society⁩ ⁦FOCAL+ 2025⁩ ⁦Focal.Therapy.UK⁩ ⁦Abhinav Sidana

Prostate calcifications are deterrents for post gland treatment modalities like #HIFU paving the way for more effective anterior gland treatment modalities of #cryotherapy and #Nanoknife 
⁦⁦<a href="/FocalSociety/">Focal Therapy Society</a>⁩ ⁦<a href="/therapy_focal/">FOCAL+ 2025</a>⁩ ⁦<a href="/UkFocal/">Focal.Therapy.UK</a>⁩ ⁦<a href="/AbhinavSidana/">Abhinav Sidana</a>⁩
Focal Therapy Society (@focalsociety) 's Twitter Profile Photo

Things taught at the Amer. Urol. Assn. #AUA2024 1- focal therapy is not about pushing a button! 2- Understand the biology of cancer 3- Imaging, Patient Selection and Follow up matter! September 19-22 2024 Endourological Society Society of Urologic Robotic Surgeons (SURS) meetings.association-service.org/fts/joint

Santosh S. Waigankar (@sandoc2005) 's Twitter Profile Photo

Intermediate-risk disease who elected primary PGCA, the five-year freedom-from-failure rate was 91 percent. This includes near- and in-field recurrences 2/3 with int-risk CaP would opt for CRYO over radical surgery.🚨 This is huge 👍🏻☑️ @ibus Urological Society of India 🇮🇳 USI Board of Educati Dr Ravimohan

Imperial Prostate (@ip_london) 's Twitter Profile Photo

🎉Congratulations to the #IP6CHAIROS study team for successfully completing recruitment of over 6️⃣0️⃣0️⃣ patients! Imperial Prostate @NIHRCRNWessex UCLH UHCW NHS Trust Chelsea and Westminster Hospital West Middlesex University Hospital Let’s keep the momentum going until completion! 💪🏻💯

🎉Congratulations to the #IP6CHAIROS study team for successfully completing recruitment of over 6️⃣0️⃣0️⃣ patients! <a href="/IP_London/">Imperial Prostate</a> @NIHRCRNWessex <a href="/uclh/">UCLH</a> <a href="/nhsuhcw/">UHCW NHS Trust</a> <a href="/ChelwestFT/">Chelsea and Westminster Hospital</a> <a href="/WestMidHospital/">West Middlesex University Hospital</a>

Let’s keep the momentum going until completion! 💪🏻💯
Santosh S. Waigankar (@sandoc2005) 's Twitter Profile Photo

🚀 Does More Biopsy = Better Outcomes in Focal Therapy? 🔍 Our #EAU25 study challenges the assumption that higher biopsy sampling density improves recurrence prediction. Findings suggest MRI visibility—not biopsy density—drives patient selection & outcomes.

🚀 Does More Biopsy = Better Outcomes in Focal Therapy? 🔍

Our #EAU25 study challenges the assumption that higher biopsy sampling density improves recurrence prediction. Findings suggest MRI visibility—not biopsy density—drives patient selection &amp; outcomes.
Santosh S. Waigankar (@sandoc2005) 's Twitter Profile Photo

🏆 Humbled to receive the Best Poster Prize at #EAU25! 🎉 Our study challenges the idea that more biopsy = better outcomes in focal therapy. Findings suggest MRI visibility—not biopsy density—drives recurrence risk. #ProstateCancer #FocalTherapy #Urology #CancerResearch @

🏆 Humbled to receive the Best Poster Prize at #EAU25! 🎉

Our study challenges the idea that more biopsy = better outcomes in focal therapy. Findings suggest MRI visibility—not biopsy density—drives recurrence risk.

#ProstateCancer #FocalTherapy #Urology #CancerResearch
@